Improve definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Hu, Yanle ^a   Esthappan, Jacqueline ^a   Mutic, Sasa ^a   Richardson, Susan ^a   Gay, Hiram A ^a   Schwarz, Julie K ^a   Grigsby, Perry W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; HDR Brachytherapy; MRI; Proton density weighting; T2 weighting

Indexed keywords

TITANIUM;

ADULT; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HISTOGRAM; HUMAN; IMAGE ANALYSIS; IMAGE GUIDED RADIOTHERAPY; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROTON DENSITY WEIGHTED MAGNETIC RESONANCE IMAGING; RADIATION APPLICATOR; RADIATION DOSE; RADIOLOGICAL PARAMETERS; UTERINE CERVIX CANCER; UTERUS;

BRACHYTHERAPY; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROGNOSIS; PROTONS; RADIOTHERAPY, IMAGE-GUIDED; RETROSPECTIVE STUDIES; TITANIUM; UTERINE CERVICAL NEOPLASMS;

EID: 84872275881     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-16     Document Type: Article

References (25)

1. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, et al. SEER Cancer Statistics Review, 1975-2007 MD: National Cancer Institute Bethesda, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
2. Nag S, Erickson B, Thomadsen E, Orton C, Demanes JD, Petereit D, Soc AB. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000, 48:201-211.
3. Patel FD, Sharma SC, Negi PS, Ghoshal S, Gupta BD. Low-Dose Rate Vs High-Dose-Rate Brachytherapy in the Treatment of Carcinoma of the Uterine Cervix - a Clinical-Trial. Int J Radiat Oncol Biol Phys 1994, 28:335-341. 10.1016/0360-3016(94)90055-8, 8276647.
4. Hareyama M, Sakata K, Oouchi A, Nagakura H, Shido M, Someya M, Koito K. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix - a randomized trial. Cancer 2002, 94:117-124. 10.1002/cncr.10207, 11815967.
5. Aird EGA, Conway J. CT simulation for radiotherapy treatment planning. Br J Radiol 2002, 75:937-949.
6. Hellebust TP, Tanderup K, Bergstrand ES, Knutsen BH, Roislien J, Olsen DR. Reconstruction of a ring applicator using CT imaging: impact of the reconstruction method and applicator orientation. Phys Med Biol 2007, 52:4893-4904. 10.1088/0031-9155/52/16/012, 17671342.
7. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999, 43:57-66. 10.1016/S0360-3016(98)00351-4, 9989514.
8. Li G, Citrin D, Camphausen K, Mueller B, Burman C, Mychalczak B, Miller RW, Song YL. Advances in 4D medical imaging and 4D radiation therapy. Technology in Cancer Research & Treatment 2008, 7:67-81.
9. Zhu J, Ma D, Lu W, Mutic S, Low D, Grigsby P. MRI-guided Radiotherapy of Cervical Carcinoma: Applications with Diffusion MRI and MR Spectroscopy. Int J Radiat Oncol Biol Phys 2009, 75:S371-S371.
10. Berger D, Dimopoulos J, Potter R, Kirisits C. Direct reconstruction of the Vienna applicator on MR images. Radiother Oncol 2009, 93:347-351. 10.1016/j.radonc.2009.07.002, 19625096.
11. De Leeuw AA, Moerland MA, Nomden C, Tersteeg RH, Roesink JM, Jurgenliemk-Schulz IM. Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer. Radiother Oncol 2009, 93:341-346. 10.1016/j.radonc.2009.05.003, 19515443.
12. Perez-Calatayud J, Kuipers F, Ballester F, Granero D, Richart J, Rodriguez S, Tormo A, Santos M. Exclusive MRI-based tandem and colpostats reconstruction in gynaecological brachytherapy treatment planning. Radiother Oncol 2009, 91:181-186. 10.1016/j.radonc.2008.09.004, 18947893.
13. Hellebust TP, Kirisits C, Berger D, Perez-Calatayud J, De Brabandere M, De Leeuw A, Dumas I, Hudej R, Lowe G, Wills R, Tanderup K. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010, 96:153-160. 10.1016/j.radonc.2010.06.004, 20663578.
14. Haack S, Nielsen SK, Lindegaard JC, Gelineck J, Tanderup K. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. Radiother Oncol 2009, 91:187-193. 10.1016/j.radonc.2008.09.002, 18977049.
15. Wills R, Lowe G, Inchley D, Anderson C, Beenstock V, Hoskin P. Applicator reconstruction for HDR cervix treatment planning using images from 0.35 T open MR scanner. Radiother Oncol 2010, 94:346-352. 10.1016/j.radonc.2009.10.015, 19931929.
16. Kim Y, Muruganandham M, Modrick JM, Bayouth JE. Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer. Int J Radiat Oncol Biol Phys 2011, 80:947-955. 10.1016/j.ijrobp.2010.07.1981, 20934275.
17. Cho ZH, Kim DJ, Kim YK. Total inhomogeneity correction including chemical shifts and susceptibility by view angle tilting. Med Phys 1988, 15:7-11. 10.1118/1.596162, 3352554.
18. Kolind SH, MacKay AL, Munk PL, Xiang QS. Quantitative evaluation of metal artifact reduction techniques. J Magn Reson Imaging 2004, 20:487-495. 10.1002/jmri.20144, 15332257.
19. Butts K, Pauly JM, Gold GE. Reduction of blurring in view angle tilting MRI. Magn Reson Med 2005, 53:418-424. 10.1002/mrm.20375, 15678535.
20. Lu W, Pauly KB, Gold GE, Pauly JM, Hargreaves BA. SEMAC: Slice Encoding for Metal Artifact Correction in MRI. Magn Reson Med 2009, 62:66-76. 10.1002/mrm.21967, 2837371, 19267347.
21. Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, Lowenstein J, Roll J, Thomadsen B, Varia M. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: Report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys 2004, 60:1160-1172. 10.1016/j.ijrobp.2004.04.032, 15519788.
22. Tanderup K, Hellebust TP, Lang S, Granfeldt J, Potter R, Lindegaard JC, Kirisits C. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol 2008, 89:156-163. 10.1016/j.radonc.2008.06.010, 18692265.
23. Jackson EF, Ginsberg LE, Schomer DF, Leeds NE. A review of MRI pulse sequences and techniques in neuroimaging. Surg Neurol 1997, 47:185-199. 10.1016/S0090-3019(96)00375-8, 9040824.
24. Sezgin M, Sankur B. Survey over image thresholding techniques and quantitative performance evaluation. Journal of Electronic Imaging 2004, 13:146-168.
25. Esthappan J, Garcia-Ramirez J, Hu Y, Grigsby PW. Transition from CT to MR Imaging of Titanium Applicators for 3D Image-Based High Dose Rate Cervix Cancer Brachytherapy. Medical Physics 2011, 38:3428.